BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1625204)

  • 21. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects.
    Foltin RW; Fischman MW
    J Pharmacol Exp Ther; 1991 Apr; 257(1):247-61. PubMed ID: 2019989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD.
    Collins SL; Levin FR; Foltin RW; Kleber HD; Evans SM
    Drug Alcohol Depend; 2006 Apr; 82(2):158-67. PubMed ID: 16213109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memantine increases cardiovascular but not behavioral effects of cocaine in methadone-maintained humans.
    Collins ED; Vosburg SK; Ward AS; Haney M; Foltin RW
    Pharmacol Biochem Behav; 2006 Jan; 83(1):47-55. PubMed ID: 16445970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily monitored cardiovascular effects of carbamazepine in chronic crack cocaine users.
    Halikas JA; Crosby RD; Koop LP; Crea F; Nugent SM; Carlson GA
    Psychopharmacol Bull; 1991; 27(3):345-51. PubMed ID: 1775609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combinations and heroin alone by rhesus monkeys.
    Mello NK; Negus SS
    J Pharmacol Exp Ther; 1998 May; 285(2):444-56. PubMed ID: 9580582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination.
    Rotheram-Fuller E; De La Garza R; Mahoney JJ; Shoptaw S; Newton TF
    Psychiatry Res; 2007 Aug; 152(2-3):205-10. PubMed ID: 17449110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.
    Tennant FS; Sagherian AA
    Arch Intern Med; 1987 Jan; 147(1):109-12. PubMed ID: 3541819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans.
    Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    Drug Alcohol Depend; 2004 Oct; 76(1):81-91. PubMed ID: 15380292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects.
    Evans SM; Cone EJ; Henningfield JE
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1345-56. PubMed ID: 8968359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.
    Walsh SL; Geter-Douglas B; Strain EC; Bigelow GE
    J Pharmacol Exp Ther; 2001 Oct; 299(1):147-58. PubMed ID: 11561074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues.
    Fox HC; Talih M; Malison R; Anderson GM; Kreek MJ; Sinha R
    Psychoneuroendocrinology; 2005 Oct; 30(9):880-91. PubMed ID: 15975729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine.
    Kumor K; Sherer M; Jaffe J
    Pharmacol Biochem Behav; 1989 Aug; 33(4):829-37. PubMed ID: 2616602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of cocaine's abuse liability in methadone maintenance patients.
    Preston KL; Sullivan JT; Strain EC; Bigelow GE
    Psychopharmacology (Berl); 1996 Jan; 123(1):15-25. PubMed ID: 8741950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily cocaine use patterns: effects of contextual and psychological variables.
    Palij M; Rosenblum A; Magura S; Handelsman L; Stimmel B
    J Addict Dis; 1996; 15(4):13-37. PubMed ID: 8943580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine-desipramine protocol in treatment of cocaine addiction.
    Giannini AJ; Billett W
    J Clin Pharmacol; 1987 Aug; 27(8):549-54. PubMed ID: 3308977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromocriptine and cocaine cue reactivity in cocaine-dependent patients.
    Kranzler HR; Bauer LO
    Br J Addict; 1992 Nov; 87(11):1537-48. PubMed ID: 1458033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromocriptine for cocaine dependence. A controlled clinical trial.
    Handelsman L; Rosenblum A; Palij M; Magura S; Foote J; Lovejoy M; Stimmel B
    Am J Addict; 1997; 6(1):54-64. PubMed ID: 9097872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
    Chausmer AL; Smith BJ; Kelly RY; Griffiths RR
    Behav Pharmacol; 2003 Mar; 14(2):111-20. PubMed ID: 12658071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose bromocriptine reverses cocaine craving.
    Dackis CA; Gold MS; Sweeney DR; Byron JP; Climko R
    Psychiatry Res; 1987 Apr; 20(4):261-4. PubMed ID: 3602212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.